Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01809002 · ClinicalTrials.gov registry record · Phase 3
Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair
A Phase 3 study, sponsored by Axogen Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 220
- Enrollment target
NCT01809002 is a Phase 3 study that has completed, run by Axogen Corporation. The registered enrollment target is 220 participants.
The verdict
NCT01809002, a Phase 3 study, has completed, sponsored by Axogen Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 220 participants
- Enrollment target
Study Summary
Processed Nerve Allograft and Collagen Nerve Cuffs will be compared to assess safety and functional outcomes for the repair of nerve injuries in the hand.
Interventions
- BIOLOGICAL Processed Nerve Allograft (human)
- DEVICE Collagen Nerve Cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2015-06 |
| Est. Completion | 2021-08-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01809002
The ClinicalTrials.gov registry entry for NCT01809002 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Axogen Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Processed Nerve Allograft (human) is the first listed.
NCT01809002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01809002 about?
NCT01809002 is a clinical study titled "Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair". Processed Nerve Allograft and Collagen Nerve Cuffs will be compared to assess safety and functional outcomes for the repair of nerve injuries in the hand.
What is the current status of trial NCT01809002?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 220 participants. The study started on 2015-06. Estimated completion is 2021-08-30.
What interventions are being tested in trial NCT01809002?
The interventions under investigation include: Processed Nerve Allograft (human) (BIOLOGICAL), Collagen Nerve Cuff (DEVICE).
Who is sponsoring clinical trial NCT01809002?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.